TITLE

A novel SRY missense mutation affecting nuclear import in a 46,XY female patient with bilateral gonadoblastoma

AUTHOR(S)
Hersmus, Remko; de Leeuw, Bertie H. C. G. M.; Stoop, Hans; Bernard, Pascal; van Doorn, Helena C.; Brüggenwirth, Hennie T.; Drop, Stenvert L. S.; Oosterhuis, J. Wolter; Harley, Vincent R.; Looijenga, Leendert H. J.
PUB. DATE
December 2009
SOURCE
European Journal of Human Genetics;Dec2009, Vol. 17 Issue 12, p1642
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Patients with disorders of sex development (DSD), especially those with gonadal dysgenesis and hypovirilization, are at risk of developing the so-called type II germ cell tumors (GCTs). Both carcinoma in situ and gonadoblastoma (GB) can be the precursor lesion, resulting in a seminomatous or non-seminomatous invasive cancer. SRY mutations residing in the HMG domain are found in 10–15% of 46,XY gonadal dysgenesis cases. This domain contains two nuclear localization signals (NLSs). In this study, we report a unique case of a phenotypical normal woman, diagnosed as a patient with 46,XY gonadal dysgenesis, with an NLS missense mutation, on the basis of the histological diagnosis of a unilateral GB. The normal role of SRY in gonadal development is the upregulation of SOX9 expression. The premalignant lesion of the initially removed gonad was positive for OCT3/4, TSPY and stem cell factor in germ cells, and for FOXL2 in the stromal component (ie, granulosa cells), but not for SOX9. On the basis of these findings, prophylactical gonadectomy of the other gonad was performed, also showing a GB lesion positive for both FOXL2 (ovary) and SOX9 (testis). The identified W70L mutation in the SRY gene resulted in a 50% reduction in the nuclear accumulation of the mutant protein compared with wild type. This likely explains the diminished SOX9 expression, and therefore the lack of proper Sertoli cell differentiation during development. This case shows the value of the proper diagnosis of human GCTs in identification of patients with DSD, which allows subsequent early diagnosis and prevention of the development of an invasive cancer, likely to be treated by chemotherapy at young age.
ACCESSION #
45272040

 

Related Articles

  • Fatal dissection of the descending aorta after implantation of a stent in a 19-year-old female with Turner's syndrome. Fejzic, Zina; van Oort, Anton // Cardiology in the Young;Oct2005, Vol. 15 Issue 5, p529 

    We report a fatal dissection of the descending aorta as a complication after a two-staged implantation of a stent to relieve aortic coarctation in a young female with Turner's syndrome. Implantation of the stent, with dilation up to 70 percent, and half a year later re-dilation to 100 percent,...

  • A patient with Turner's syndrome associated with unexplained left ventricular hypertrophy, severe left ventricular systolic dysfunction, atrial septal defect and pericardial effusion. Özaydın, Mehmet; Varol, Ercan; Okutan, Hüseyin; Peker, Oktay; Doǧan, Abdullah; Altınbaş, Ahmet; Kahraman, Halil // Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi;Jun2007, Vol. 7 Issue 2, p237 

    The article presents the case of a 40-year-old female diagnosed with Turner's syndrome. Her condition is associated with unexplained left ventricular hypertrophy, severe left ventricular systolic dysfunction, atrial septal defect and pericardial effusion. There is high prevalence of congenital...

  • Gonadoblastoma Associated with Pure Gonadal Dysgenesis. Similä, S.; Jukarainen, E.; Herva, R.; Heikkinen, E. S. // Clinical Pediatrics;Feb1974, Vol. 13 Issue 2, p177 

    A prepubertal girl with pure gonadal dysgenesis and 46, XY karyotype is reported. Exploratory laparotomy was performed and bilateral gonadal streaks and a small left gonadal tumor were found at the place of the ovaries. The pathologic examination of this tumor revealed gonadoblastoma. The...

  • A multicentre trial of recombinant growth hormone and low dose oestrogen in Turner syndrome: near final height analysis. Johnston, D. I.; Betts, P.; Dunger, D.; Barnes, N.; Swift, P. G. F.; Buckler, J. M. H.; Butler, G. E. // Archives of Disease in Childhood;Jan2001, Vol. 84 Issue 1, p76 

    Background-Turner syndrome accounts for 15-20% of childhood usage of growth hormone (GH) in the UK but final height benefit remains uncertain. The most effective strategy for oestrogen replacement is also unclear. Methods-Fifty eight girls who, at start of treatment, were of mean age 9.1 years...

  • High Risk of Death During Pregnancy Exists for Women With Turner Syndrome.  // Fertility Weekly;10/6/2003, p8 

    Reports that women with Turner syndrome are at high risk for death during pregnancy. Influence of aortic rupture or dissection on the high risk; Presence of an associated cardiovascular malformation; Number of deaths among Turner syndrome patients that achieved pregnancy through oocyte donation.

  • 'Pseudoerysipelas" in a Child with Turner's Syndrome. Randolph, Christopher; Faden, Howard // Clinical Pediatrics;Jan1985, Vol. 24 Issue 1, p34 

    Examines a case study of a pseudoerysipelas in a child with Turner's Syndrome. Medical history of the patient; Signs and symptoms; Medical analysis on the health condition of the patient.

  • Anorexia Nervosa and Turner's Syndrome. Fieldsen, Bob // British Journal of Psychiatry;Feb88, Vol. 152, p270 

    A case is described of a patient with Turners mosaic (XO/XX) associated with anorexia nervosa. The cases described in the literature point towards the multifactorial aetiology of anorexia nervosa, emphasising factors other than the suppression of sexuality.

  • The X Isochromosome-X Syndrome [46,X,i(Xq)]. Santana, Joáo A. M.; Gardner, Lytt I.; Neu, Richard L. // Clinical Pediatrics;Nov1977, Vol. 16 Issue 11, p1021 

    It is important not to confuse the 46,X,i(Xq) syndrome with the 45X classical Turner's syndrome. There are profound cytogenetic and clinical differences between the two syndromes, which must be borne in mind in the differential diagnosis of amenorrhea and of infertility.

  • Turner's syndrome presenting as metabolic bone disease. Kamalanathan, Sadishkumar; Balachandran, Karthik; Ananthakrishnan, Ramesh; Hamide, Abdoul // Indian Journal of Endocrinology & Metabolism;Jul/Aug2012, Vol. 16 Issue 4, p637 

    Turner's syndrome is a genetic disorder with a complete or partial absence of one X chromosome with characteristic phenotypic features. The prevalence of renal anomalies in turner syndrome is 30-40%. However, the renal function is usually normal. We report a case of Turner's syndrome presenting...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics